SweeGen Inc announces FDA No Objection Letter for BESTEVIA Reb E stevia leaf sweetener.
Global Banking News-June 26, 2019-SweeGen Inc announces FDA No Objection Letter for BESTEVIA Reb E stevia leaf sweetener
(C)2019 ENPublishing - http://www.enpublishing.co.uk
Sweetener company SweeGen Inc said on Tuesday that it has received the GRAS (Generally Recognized As Safe) No Objection Letter for BESTEVIA Rebaudioside E (Reb E) stevia leaf sweetener for use in foods from the US Food and Drug Administration (FDA).
According to the company, BESTEVIA e+ shows great success in reducing sugar and artificial sweeteners in many applications, such as beverage, dairy, sports nutrition, condiments and bakeries. BESTEVIA e+ provides a clean, sugar-like taste at a price equivalent to sugar.
The company added that the BESTEVIA Reb E, a non-caloric, high-purity stevia sweetener, is produced from the stevia leaf through the US FDA evalueted non-GMO bioconversion process.
Following the US FDA No Objection Letter, the company added that will continue to pursue global approvals of the BESTEVIA Rebaudioside E (Reb E) stevia leaf sweetener for use in foods.
((Distributed via M2 Communications - http://www.m2.com))
|Printer friendly Cite/link Email Feedback|
|Publication:||Global Banking News (GBN)|
|Date:||Jun 26, 2019|
|Previous Article:||Greenlane wins new CAD3.4m biogas upgrading contract in Canada.|
|Next Article:||International Petroleum commences drilling programme in Malaysia.|